HER2 and other tumor-associated antigens — Drug Target

All drugs that target HER2 and other tumor-associated antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Dendritic cell vaccine

Phase 3 pipeline (1)

• GLSI-100 · Greenwich LifeSciences, Inc. · Dendritic cell vaccine · Oncology
  GLSI-100 is an autologous dendritic cell vaccine designed to stimulate the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.